Retention Implementation Guide
1.0.0 - ci-build
Retention Implementation Guide - Local Development build (v1.0.0). See the Directory of published versions
| Active as of 2022-11-28 |
<CodeSystem xmlns="http://hl7.org/fhir">
<id value="Medication"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p>This code system <code>https://www.retention-project.eu/ig/CodeSystem/Medication</code> defines the following codes:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style="white-space:nowrap">200<a name="Medication-200"> </a></td><td>ACEi</td><td>ACEi</td></tr><tr><td style="white-space:nowrap">201<a name="Medication-201"> </a></td><td>ARBs</td><td>ARBs</td></tr><tr><td style="white-space:nowrap">202<a name="Medication-202"> </a></td><td>Sacubitril/valsartan</td><td>Sacubitril/valsartan</td></tr><tr><td style="white-space:nowrap">203<a name="Medication-203"> </a></td><td>Beta-blocker</td><td>Beta-blocker</td></tr><tr><td style="white-space:nowrap">204<a name="Medication-204"> </a></td><td>MRA</td><td>MRA</td></tr><tr><td style="white-space:nowrap">205<a name="Medication-205"> </a></td><td>SGLT2i</td><td>SGLT2i</td></tr><tr><td style="white-space:nowrap">206<a name="Medication-206"> </a></td><td>Ivabradine</td><td>Ivabradine</td></tr><tr><td style="white-space:nowrap">207<a name="Medication-207"> </a></td><td>Vericiguat</td><td>Vericiguat</td></tr><tr><td style="white-space:nowrap">208<a name="Medication-208"> </a></td><td>Digoxin</td><td>Digoxin</td></tr><tr><td style="white-space:nowrap">209<a name="Medication-209"> </a></td><td>Vasodilators</td><td>Vasodilators</td></tr><tr><td style="white-space:nowrap">210<a name="Medication-210"> </a></td><td>Antiplatelets</td><td>Antiplatelets</td></tr><tr><td style="white-space:nowrap">211<a name="Medication-211"> </a></td><td>Anticoagulants</td><td>Anticoagulants</td></tr><tr><td style="white-space:nowrap">212<a name="Medication-212"> </a></td><td>Loop diuretics</td><td>Loop diuretics</td></tr><tr><td style="white-space:nowrap">213<a name="Medication-213"> </a></td><td>Thiazides</td><td>Thiazides</td></tr><tr><td style="white-space:nowrap">214<a name="Medication-214"> </a></td><td>Potassium sparing diuretics</td><td>Potassium sparing diuretics</td></tr><tr><td style="white-space:nowrap">215<a name="Medication-215"> </a></td><td>Potassium supplements</td><td>Potassium supplements</td></tr><tr><td style="white-space:nowrap">216<a name="Medication-216"> </a></td><td>Potassium binders</td><td>Potassium binders</td></tr><tr><td style="white-space:nowrap">217<a name="Medication-217"> </a></td><td>Statins</td><td>Statins</td></tr><tr><td style="white-space:nowrap">218<a name="Medication-218"> </a></td><td>Ezetimibe</td><td>Ezetimibe</td></tr><tr><td style="white-space:nowrap">219<a name="Medication-219"> </a></td><td>Other Antihyperlipidemic Drugs</td><td>Other Antihyperlipidemic Drugs</td></tr><tr><td style="white-space:nowrap">220<a name="Medication-220"> </a></td><td>Calcium Channel Blockers</td><td>Calcium Channel Blockers</td></tr><tr><td style="white-space:nowrap">221<a name="Medication-221"> </a></td><td>Amiodarone</td><td>Amiodarone</td></tr><tr><td style="white-space:nowrap">222<a name="Medication-222"> </a></td><td>Other antiarrhythmics</td><td>Other antiarrhythmics</td></tr><tr><td style="white-space:nowrap">223<a name="Medication-223"> </a></td><td>PPI</td><td>PPI</td></tr><tr><td style="white-space:nowrap">224<a name="Medication-224"> </a></td><td>Steroids</td><td>Steroids</td></tr><tr><td style="white-space:nowrap">225<a name="Medication-225"> </a></td><td>Immediate release (Prograft)</td><td>Immediate release (Prograft)</td></tr><tr><td style="white-space:nowrap">226<a name="Medication-226"> </a></td><td>Slow release (Advagraft)</td><td>Slow release (Advagraft)</td></tr><tr><td style="white-space:nowrap">227<a name="Medication-227"> </a></td><td>Extended release (Envarsus)</td><td>Extended release (Envarsus)</td></tr><tr><td style="white-space:nowrap">228<a name="Medication-228"> </a></td><td>Everolimus</td><td>Everolimus</td></tr><tr><td style="white-space:nowrap">229<a name="Medication-229"> </a></td><td>Ciclosporin</td><td>Ciclosporin</td></tr><tr><td style="white-space:nowrap">230<a name="Medication-230"> </a></td><td>Mycophenolate mofetil</td><td>Mycophenolate mofetil</td></tr><tr><td style="white-space:nowrap">231<a name="Medication-231"> </a></td><td>Mycophenolate sodium</td><td>Mycophenolate sodium</td></tr><tr><td style="white-space:nowrap">232<a name="Medication-232"> </a></td><td>Antibiotics</td><td>Antibiotics</td></tr><tr><td style="white-space:nowrap">233<a name="Medication-233"> </a></td><td>Insulin</td><td>Insulin</td></tr><tr><td style="white-space:nowrap">234<a name="Medication-234"> </a></td><td>Other Antidiabetics</td><td>Other Antidiabetics</td></tr></table></div>
</text>
<url value="https://www.retention-project.eu/ig/CodeSystem/Medication"/>
<version value="1.0.0"/>
<name value="Medication"/>
<title value="Medication Codesystem"/>
<status value="active"/>
<experimental value="true"/>
<date value="2022-11-28T14:27:31+02:00"/>
<description value="Code system for Medication groups"/>
<caseSensitive value="false"/>
<content value="complete"/>
<count value="35"/>
<concept>
<code value="200"/>
<display value="ACEi"/>
<definition value="ACEi"/>
</concept>
<concept>
<code value="201"/>
<display value="ARBs"/>
<definition value="ARBs"/>
</concept>
<concept>
<code value="202"/>
<display value="Sacubitril/valsartan"/>
<definition value="Sacubitril/valsartan"/>
</concept>
<concept>
<code value="203"/>
<display value="Beta-blocker"/>
<definition value="Beta-blocker"/>
</concept>
<concept>
<code value="204"/>
<display value="MRA"/>
<definition value="MRA"/>
</concept>
<concept>
<code value="205"/>
<display value="SGLT2i"/>
<definition value="SGLT2i"/>
</concept>
<concept>
<code value="206"/>
<display value="Ivabradine"/>
<definition value="Ivabradine"/>
</concept>
<concept>
<code value="207"/>
<display value="Vericiguat"/>
<definition value="Vericiguat"/>
</concept>
<concept>
<code value="208"/>
<display value="Digoxin"/>
<definition value="Digoxin"/>
</concept>
<concept>
<code value="209"/>
<display value="Vasodilators"/>
<definition value="Vasodilators"/>
</concept>
<concept>
<code value="210"/>
<display value="Antiplatelets"/>
<definition value="Antiplatelets"/>
</concept>
<concept>
<code value="211"/>
<display value="Anticoagulants"/>
<definition value="Anticoagulants"/>
</concept>
<concept>
<code value="212"/>
<display value="Loop diuretics"/>
<definition value="Loop diuretics"/>
</concept>
<concept>
<code value="213"/>
<display value="Thiazides"/>
<definition value="Thiazides"/>
</concept>
<concept>
<code value="214"/>
<display value="Potassium sparing diuretics"/>
<definition value="Potassium sparing diuretics"/>
</concept>
<concept>
<code value="215"/>
<display value="Potassium supplements"/>
<definition value="Potassium supplements"/>
</concept>
<concept>
<code value="216"/>
<display value="Potassium binders"/>
<definition value="Potassium binders"/>
</concept>
<concept>
<code value="217"/>
<display value="Statins"/>
<definition value="Statins"/>
</concept>
<concept>
<code value="218"/>
<display value="Ezetimibe"/>
<definition value="Ezetimibe"/>
</concept>
<concept>
<code value="219"/>
<display value="Other Antihyperlipidemic Drugs"/>
<definition value="Other Antihyperlipidemic Drugs"/>
</concept>
<concept>
<code value="220"/>
<display value="Calcium Channel Blockers"/>
<definition value="Calcium Channel Blockers"/>
</concept>
<concept>
<code value="221"/>
<display value="Amiodarone"/>
<definition value="Amiodarone"/>
</concept>
<concept>
<code value="222"/>
<display value="Other antiarrhythmics"/>
<definition value="Other antiarrhythmics"/>
</concept>
<concept>
<code value="223"/>
<display value="PPI"/>
<definition value="PPI"/>
</concept>
<concept>
<code value="224"/>
<display value="Steroids"/>
<definition value="Steroids"/>
</concept>
<concept>
<code value="225"/>
<display value="Immediate release (Prograft)"/>
<definition value="Immediate release (Prograft)"/>
</concept>
<concept>
<code value="226"/>
<display value="Slow release (Advagraft)"/>
<definition value="Slow release (Advagraft)"/>
</concept>
<concept>
<code value="227"/>
<display value="Extended release (Envarsus)"/>
<definition value="Extended release (Envarsus)"/>
</concept>
<concept>
<code value="228"/>
<display value="Everolimus"/>
<definition value="Everolimus"/>
</concept>
<concept>
<code value="229"/>
<display value="Ciclosporin"/>
<definition value="Ciclosporin"/>
</concept>
<concept>
<code value="230"/>
<display value="Mycophenolate mofetil"/>
<definition value="Mycophenolate mofetil"/>
</concept>
<concept>
<code value="231"/>
<display value="Mycophenolate sodium"/>
<definition value="Mycophenolate sodium"/>
</concept>
<concept>
<code value="232"/>
<display value="Antibiotics"/>
<definition value="Antibiotics"/>
</concept>
<concept>
<code value="233"/>
<display value="Insulin"/>
<definition value="Insulin"/>
</concept>
<concept>
<code value="234"/>
<display value="Other Antidiabetics"/>
<definition value="Other Antidiabetics"/>
</concept>
</CodeSystem>
IG © 2022+ . Package Retention#1.0.0 based on FHIR 4.0.1. Generated 2022-12-21
Links: Table of Contents |
QA Report